National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 5,957 cases where Vaccine is VARZOS and Serious and Submission Date on/before '2015-09-30'

Government Disclaimer on use of this data



Case Details

This is page 4 out of 596

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13   next


VAERS ID: 277354 (history)  
Form: Version 1.0  
Age: 70.0  
Sex: Male  
Location: California  
Vaccinated:0000-00-00
Onset:2007-04-11
Submitted: 2007-04-24
   Days after onset:13
Entered: 2007-04-25
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Abdominal pain, Computerised tomogram normal, Flank pain
SMQs:, Acute pancreatitis (broad), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: computed axial 04/11?/07 - no abnormalities
CDC Split Type: WAES0704USA02830

Write-up: Information has been received from a 70 year old male physician who in 2006 was vaccinated with a dose of Zostavax. On 11-APR-2007 the physician experienced pain on right flank area and right abdominal area. Unspecified medical attention was sought. A CAT scan on the affected area showed no abnormalities. There were no zoster-like lesions present. At the time of the report the physician had not recovered. There was no product quality complaint involved. The physician considered his pain on right flank area and right abdominal area to be disabling. Additional information has been requested.


VAERS ID: 277477 (history)  
Form: Version 1.0  
Age: 65.0  
Sex: Male  
Location: Tennessee  
Vaccinated:2007-04-05
Onset:2007-04-14
   Days after vaccination:9
Submitted: 2007-04-26
   Days after onset:12
Entered: 2007-04-27
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 1212F / UNK RA / IM

Administered by: Other       Purchased by: Other
Symptoms: Anoxic encephalopathy, Blood glucose increased, Carpal tunnel syndrome, Encephalitis, Endotracheal intubation, Inguinal hernia, Monocyte count decreased, Neutrophil count increased
SMQs:, Angioedema (broad), Haematopoietic leukopenia (narrow), Hyperglycaemia/new onset diabetes mellitus (narrow), Ischaemic central nervous system vascular conditions (narrow), Noninfectious encephalitis (narrow), Noninfectious encephalopathy/delirium (narrow), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2007-10-13
   Days after onset: 182
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 30 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown PMH: IDDM. Recent URI. Obstructive sleep apnea. Bells palsy x 2 in past 2 years. HTN, hypercholesterolemia.
Allergies:
Diagnostic Lab Data: Unknown LABS from pcp: HgA1C elevated at 9.1, high triglycerides & cholesterol. LABS from hospital: CT & MRI of brain were WNL. EEGs abnormal showing seizure activity & generalized severe encephalopathy. WBC 30,000, Creatinine 4.3, BUN 55, AST 550, ALT 157. CPK 61299. CK MB 82, Troponin 0.15. CSF protein 171, glucose 167, WBC 29, polys 14, neutros 14, lymphs 74, monos 12, c/s neg.Blood c/s (+). Urine & stool c/s (-). Doppler of legs (-).
CDC Split Type: WAES0704USA03666

Write-up: Information has been received from a physician concerning a male who on 05-APR-2007 was vaccinated with a single dose of Zostavax. On 14-APR-2007 (also reported as 17-APR-2007) the patient experienced "encephalitis" and was hospitalized. It was reported that the patient was air lifted to a hospital and was in the ICU. There was no product quality complaint involved. No further information. Additional information has been requested. 5/1/07 T/C to reporter to request missing info. Received patient demographics. 6/15/07 Received provider medical records which included vax lot #. VAERS database updated. Seen in PCP office on 4/5/07 for diet consult re diabetes, wt 301. left inguinal hernia & possible right hand CTS noted. 8/21/07 Received hospital medical records which reveal patient experienced unresponsiveness while at home. Out of state daughter called EMS when no response. Daughter stated patient had c/o stiff neck, sour stomach, weakness & febrile to 104 since zostavax on 4/5/07. Found to be unresponsive w/rash on abdominal area. Glucose was 326. Intubated & helicoptered to ER. Admitted 4/14-5/14/07. Found to be in acute renal failure secondary to rhabdomyolysis & hypotension. Tx w/hemodialysis, pressors, antivirals & antibiotics. Nephrology, neurology & ID consults done. Trached & weaned to trach collar oxygen, feeding tube placement. Weaned from hemodialysis & renal function slowly improving. Remained in comatose state w/poor prognosis at transfer. FINAL DX: viral meningitis, anoxic brain injury. 7/25/08-ventricular arrhythmia. arteriosclerotic cardiovascular disease. 1/4/2010 My brother died Oct 13, 2007. There were mistakes performed in medical center which caused him to go without 02 for 15 minutes. He was only minimaly conscious after that point.


VAERS ID: 277573 (history)  
Form: Version 1.0  
Age: 60.0  
Sex: Female  
Location: California  
Vaccinated:2007-01-30
Onset:2007-02-06
   Days after vaccination:7
Submitted: 2007-04-27
   Days after onset:79
Entered: 2007-04-30
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Private       Purchased by: Other
Symptoms: Bedridden, Bruxism, Computerised tomogram normal, Cystitis, Deafness, Dizziness, Ear discomfort, Facial pain, Limb discomfort, Nuclear magnetic resonance imaging normal, Sinusitis, Syncope, Tendonitis, Tinnitus, Tooth abscess, Vertigo
SMQs:, Torsade de pointes/QT prolongation (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Glaucoma (broad), Cardiomyopathy (broad), Hearing impairment (narrow), Vestibular disorders (narrow), Osteonecrosis (broad), Hypotonic-hyporesponsive episode (broad), Tendinopathies and ligament disorders (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: [therapy unspecified], estrogens (unspecified)
Current Illness:
Preexisting Conditions: Penicillin allergy; Sulfonamide allergy; Drug hypersensitivity; Allergic reaction to antibiotics
Allergies:
Diagnostic Lab Data: computed axial 03/04/07 - negative, magnetic resonance 03/04?/07 - acoustic nerve OK
CDC Split Type: WAES0704USA02146

Write-up: Information has been received from a female consumer who on 30-JAN-2007 was vaccinated with a dose of Zostavax. Concomitant therapy included hormone replacement therapy and "standard medications." Ten days later vaccination, on 09-FEB-2007 the patient was experiencing vertigo, hearing loss and tendonitis. The patient stated that she had to go to the emergency room and get an MRI and CT scan and that she has seen her doctor many times. There was no product quality complaint involved. Additional information was received from the physician. A 60 year old white female with allergies to penicillin, sulfa, cefixime (SUPRAX), levofloxacin (LEVAQUIN), metronidazole (FLAGYL), cefdinir (OMNICEF), ramelton (ROZEREM), duloxetine hydrochloride (CYMBALTA) and doxycycline, was vaccinated with a dose of Zostavax on 30-JAN-2007. On 06-FEB-2007 the patient''s ears were plugged "ETD". on 08-FEB-2007 the patient developed cystitis and was treated with azithromycin (Z-PAK), phenazopyridine hydrochloride (PYRIDIUM) and fluconazole (DIFLUCAN). On 20-FEB-2007 the patient was diagnosed with sinusitis and was treated with clarithromycin (BIAXIN), fluticasone propionate (FLONASE), guaifenesin (MUCINEX), acetaminophen (+) propoxyphene napsylate (DARVOCET-N) and "ETD.". On 27-FEB-2007 the patient''s prescription was changed to gemifloxacin mesylate (FACTIVE). On 01-MAR-2007 the patient saw an ENT and it was noted that her left arm was blocked, the patient was treated with prednisone. On 04-MAR-2007 the patient fainted at the gym 1 1/2 hours after steam and the patient was dizzy. The patient presented to the ER where a CT scan was "negative." It was reported that since 04-MAR-2007 the patient has been bedridden with dizziness. The patient was again seen on 20-MAR-2007 and ENT had done an MRI which showed that the acoustic nerve was "OK." It was reported that the patient is now with hearing loss, tinnitus and dizziness being treated with hydrochlorothiazide (+) triamterene (DYAZIDE). Subsequently the patient developed facial pains and was diagnosed with a dental abscess and treated with clindamycin, then ciprofloxacin hydrochloride (CIPRO) and now a mouth piece for teeth grinding. The hydrochlorothiazide (+) trimaterene (DYAZIDE) was stopped and the patient developed severe incapacitating vertigo x 3 days. At the time of the report the patient had some improvement with dizziness, it was possible that her hearing loss was less and she still had tinnitus. The patient had a hearing test with her ENT which showed left hearing loss. At the time of the report the patient had not recovered. No further information was provided. The patient''s events were considered disabiling/incapacitating. No further information is available.


VAERS ID: 277574 (history)  
Form: Version 1.0  
Age: 65.0  
Sex: Male  
Location: South Carolina  
Vaccinated:2007-04-16
Onset:2007-04-16
   Days after vaccination:0
Submitted: 2007-04-27
   Days after onset:11
Entered: 2007-04-30
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0329U / UNK - / SC

Administered by: Other       Purchased by: Other
Symptoms: Hypoaesthesia, Neuralgia, Tinnitus
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (broad), Hearing impairment (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: aspirin, DIOVAN, vitamin b complex
Current Illness:
Preexisting Conditions: Neuropathy; Hypertension; Hyperlipidaemia; Drug hypersensitivity
Allergies:
Diagnostic Lab Data: None
CDC Split Type: WAES0704USA04543

Write-up: Information has been received from a physician concerning a 65 year old male with neuropathy, hypertension, hyperlipidaemia and allergies to rofecoxib (WAES # 0704USA05632), statins and codeine, who on 16-APR-2007 was vaccinated SC with a 0.5 ml dose of Zostavax (lot # 656861/0329U). Concomitant therapy included Diovan, aspirin and vitamin B complex. On 16-APR-2007 the patient developed extreme neuropathic pain and numbness to his hands and feet after vaccination. He also reported tinnitus. Unspecified medical attention was sought. There were no lab or diagnostic tests performed. At the time of the report the patient had not recovered. There was no product quality complaint involved. The patient''s events were considered disabling. Additional information has been requested.


VAERS ID: 277901 (history)  
Form: Version 1.0  
Age: 79.0  
Sex: Female  
Location: Texas  
Vaccinated:2007-04-10
Onset:2007-04-11
   Days after vaccination:1
Submitted: 2007-05-03
   Days after onset:22
Entered: 2007-05-04
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0981F / UNK - / SC

Administered by: Other       Purchased by: Other
Symptoms: Allergy to vaccine, Choking sensation, Drug hypersensitivity, Influenza like illness, Respiratory disorder, Throat tightness
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Hypersensitivity (narrow), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Hypertension
Preexisting Conditions: Psoriasis; Poliomyelitis; Cataract
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0704USA05553

Write-up: Information has been received from a physician and a medical assistant concerning a 79 year old female with hypertension and a history of psoriasis, polio, and cataracts and no prior history of respiratory problems who in the morning of 01-APR-2007 was vaccinated SC (also reported as IM) with a 0.65 ml dose of Zostavax (lot # 652936/0981F). The next morning, on 11-APR-2007, she started getting flu-like symptoms. By noon, she started having more severe symptoms, to the extent that she started having a choking feeling. She developed respiratory problems and was admitted to the hospital. She spent one night (24 hours) in the hospital and was found to have had an allergic reaction to Zostavax and a throat spasm. She was given antihistaminic and steroids. She was discharged the following morning and was recovered and was "completely fine". The physician felt that the patient''s experiences were related to therapy with Zostavax. Additional information has been requested.


VAERS ID: 278000 (history)  
Form: Version 1.0  
Age: 65.0  
Sex: Male  
Location: Michigan  
Vaccinated:2007-02-26
Onset:2007-02-26
   Days after vaccination:0
Submitted: 2007-05-04
   Days after onset:66
Entered: 2007-05-07
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 1477F / UNK UN / SC

Administered by: Other       Purchased by: Other
Symptoms: Dizziness, Feeling abnormal, Heart rate decreased, Herpes zoster, Loss of consciousness, Malaise, Respiratory arrest
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dementia (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (broad), Respiratory failure (narrow), Hypoglycaemia (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Voltaren, Advair, Prinivil
Current Illness: Sleep disorder
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: total heartbeat count 03/11/07 25
CDC Split Type: WAES0704USA05041

Write-up: Information has been received from a medical receptionist concerning a 65 year old male with "sleeping issues" who on 26-FEB-2007 was vaccinated SC with a 0.65 ml dose of Zostavax (lot # 656413/1477). Suspect therapy included lisinopril (manufacturer unknown), tablet (dose , duration and induration not reported). Other concomitant therapy Advair and Voltaren. There was no illness at the time of vaccination. The patient''s wife reported that on the day of vaccination (after vaccination) the patient "didn''t feel very good." On 11-MAR-2007 the patient reportedly passed out and stopped breathing. EMS was called and the patient was admitted to the hospital. It was also reported that the patient''s heart rate dropped to 25. The patient did not have a detectable heart problem. On 15-MAR-2007 the patient was discharged from the hospital. On 22-MAR-2007 it was noted that the patient developed shingles on the left thigh and abdomen (the rash was described as both a shingles like rash and a varicella like rash but was diagnosed by the physician as shingles on 29-MAR-2007). Subsequently the patient was "recently" seen in the office and he was doing better but he still wasn''t feeling great and still had some of the shingles rash. The patient was also still feeling "fluttering" in his neck and was sometimes lightheaded. The patient was still recovering from his hospitalization. On 01-MAY-2007 the patient passed out again and was hospitalized. The patient''s status at that time was unknown. There was no product quality complaint involved. No further information was provided. Additional information has been requested.


VAERS ID: 278134 (history)  
Form: Version 1.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:2007-04-20
Onset:2007-04-21
   Days after vaccination:1
Submitted: 2007-05-07
   Days after onset:16
Entered: 2007-05-08
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (ENGERIX-B) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / UN
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0329U / UNK UN / UN

Administered by: Unknown       Purchased by: Unknown
Symptoms: Erythema, Eyelid oedema, Facial pain, Herpes zoster, Pain, Rash macular, Swelling, Tenderness
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Glaucoma (broad), Periorbital and eyelid disorders (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: None
CDC Split Type: WAES0705USA00744

Write-up: Information has been received from a public health nurse concerning a male (age unknown) who on 20-APR-2007 was vaccinated with a dose of Zostavax (656561/0329U). Suspect therapy included ENGERIX-B. It was reported by the public health nurse, that she heard the male client is a professor at a local college, was vaccinated at the health department on 20-Apr-2007 and developed shingles. The client kept a log of events and followed up with his primary care physician. Nurse stated the primary HCP is aware of the VZV ID program, but did not take a specimen because there was no blisters or fluid filled vesicle formation, just red blotch. Client told the nurse on Day 2, he had 30 to 35 millimeters of redness over the left temple. Day 3, there was swelling under the reddened area, scalp and upper face tender to the touch. Day 4, tenderness of neck region below the left era, at the angel of the mandible. On a pain scale of 1 to 10, with 10 being the highest, client rated pain at a 6 or 7. Day 5, client consulted with his primary care physician. No blisters, no vesicle formation, just red blotch. No VZV analysis performed. Client treated with half of vicodin. Day 6, left eyelid had swelling and facial pain, served by "cranial V2." Day 7, eyelid swollen pain reduced. Day 9, neck pain gone, eyelid normal. Day 10, "pain persists in the area of cranial V1:. Day 12, client told nurse on a scale of 1 to 10, with 10 being the highest, he was at pain level 2. Client is recovering. Unspecified medical attention was sought. This event was considered serious by the patient as a significant disability or incapacity. No product quality complaint. No further information is available.


VAERS ID: 278245 (history)  
Form: Version 1.0  
Age: 63.0  
Sex: Female  
Location: Indiana  
Vaccinated:2006-12-01
Onset:2007-04-08
   Days after vaccination:128
Submitted: 2007-05-04
   Days after onset:26
Entered: 2007-05-09
   Days after submission:5
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: Unknown
Symptoms: Herpes zoster ophthalmic, Necrotising retinitis, Vision blurred
SMQs:, Anticholinergic syndrome (broad), Glaucoma (broad), Lens disorders (broad), Retinal disorders (narrow), Ocular infections (narrow), Hypoglycaemia (broad), Opportunistic infections (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: PMH: oral herpes simplex in distant past. Recent URI while traveling abroad. Basal cell ca of left temple. Hypothyroidism s/p thyroidectomy. Left facial cellulitis requiring hospitalization. ruptured lumbar disk recently treated w/epidural block & oral steroids. right breast ca
Allergies:
Diagnostic Lab Data: LABS: CBC was WNL. Chemistry was WNL. HSV 1 & 2 IgG & IgM were neg. VZ IgG & IgM were neg. CXR was WNL.
CDC Split Type:

Write-up: Patient presented to eye doctor with blurred vision in right eye. Patient admitted to hospital with acute retinal necrosis with herpes zoster in right eye. Patient was hospitalized short-term while receiving acyclovir IV therapy. Patient was discharged to home with home health services to continue acyclovir therapy. Situation was not resolved upon hospital discharge. 5/18/07 Received medical records from hospital which reveal patient experienced pain & decreased vision of right eye & saw opthal who noted retinal abnormalities. Vision worsened to blindness of right eye & acute retinal necrosis. Admitted 4/6-4/9/07. ID consult done. Treated w/IV antiviral. PICC line placed for continued IV antiviral as outpatient for total of 14 days then to begin oral antivirals. FINAL DX: acute retinal necrosis, right side, likely secondary to herpes zoster s/p vaccine. Patient''s condition (necrotizing retinitis) was noted to be improving per physician.


VAERS ID: 278495 (history)  
Form: Version 1.0  
Age: 76.0  
Sex: Female  
Location: Maryland  
Vaccinated:2007-04-25
Onset:2007-04-25
   Days after vaccination:0
Submitted: 2007-05-11
   Days after onset:16
Entered: 2007-05-14
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Anaphylactic reaction, Muscle tightness, Palpitations, Throat tightness
SMQs:, Anaphylactic reaction (narrow), Angioedema (broad), Arrhythmia related investigations, signs and symptoms (broad), Anaphylactic/anaphylactoid shock conditions (narrow), Dystonia (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Cardiomyopathy (broad), Hypersensitivity (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Drug hypersensitivity
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0705USA00599

Write-up: Information has been received from a physician concerning a 76 year old female with drug hypersensitivity who experienced an anaphylactic reaction on 25-APR-2007 after being vaccinated with a .65 ml dose of Zostavax. The reaction was described as racing heart, felt like throat was closing up, and tightness of the neck. The patient carries Benadryl Elixir 50 due to sensitivity to medication, which was administered. The patient was taken to the ER and administered IV famotidine and IV steroids. The patient was kept overnight for observation and released the next day. There was no product quality complaint. Additional information has been requested.


VAERS ID: 278688 (history)  
Form: Version 1.0  
Age: 79.0  
Sex: Female  
Location: Unknown  
Vaccinated:2007-03-09
Onset:2007-03-16
   Days after vaccination:7
Submitted: 2007-05-15
   Days after onset:60
Entered: 2007-05-16
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 00324 / UNK LA / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2007-03-16
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown PMH: cholelithiasis, symptomatic but deferred surgery. Positive PPD in past. Ex-smoker. HCM, HOH, hypercholesterolemia, transaminase, insomnia, osteopenia, glaucoma, cataracts, GERD/IBS,
Allergies:
Diagnostic Lab Data: Unknown LABS: EKG showed ST elevations. Troponin 4.44. CXR showed clear lungs. AST 69, Ca 7.7, t. protein 4.4. RBC 3.02, H/H 9.7/29.9, lymphs 5.9, monos 0.8. HBA1C 8.2, free testosterone 7.1
CDC Split Type: WAES0705USA00976

Write-up: Information has been received from a medical assistant concerning a patient who approximately one month ago on 03-APR-2007 was vaccinated with a dose of zoster vaccine live. Within a week, the patient died of a heart attack. No additional information was provided. Additional ifnormation has been requested. 5/18/07 Received records from reporter which included Death Certificate which reveals COD as Inferior myocardial infarction. Records from PCP incidate patient had tetanus updated 1/24/07. Records from ER of 3/16/07 indicate patient seen for syncope or unresponsiveness when passed out in church after complaining to friends that she did not feel well for several days because of her gallbladder. EMS called. BP was unobtainable. Started on Dopamine & given IV fluid bolus. Denied pain & good respiratory effort but restless. O2 sats remained in high 80''s but w/poor perfusion signal. Preparing to administer thrombolytics when became unresponsive & lost pulse. Intubated & coded but unsuccessful resuscitation. FINAL ER DX: acute myocardial infarction, perhaps remote w/continued expansion of infarct leading to cardiopulmonary decline.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=4&VAX=VARZOS&SERIOUS=ON&SUB_YEAR_HIGH=2015&SUB_MONTH_HIGH=09


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166